Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-Analysis.

Insulin resistance brain glucose metabolism brain glucose uptake obesity type 2 diabetes

Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
24 Aug 2024
Historique:
received: 12 04 2024
revised: 15 07 2024
accepted: 23 08 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: aheadofprint

Résumé

Abnormal brain glucose metabolism may cause cognitive disease in type 2 diabetes, yet the relation between insulin resistance and brain glucose metabolism has not been systematically described. We evaluated the impact of metabolic condition (fasting vs insulin stimulation, e.g., from hyperinsulinemic clamp) on the association between insulin resistance of different etiologies and brain glucose metabolism. PubMed, Embase, Cochrane Library, and Web of Science were systematically searched from inception until February 2022. Of 656 unique records, we deemed thirty-one eligible. Criteria were studies assessing brain glucose metabolism (uptake or metabolic rate) by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography ([18F]-FDG-PET) in individuals characterized by measures of or clinical proxies for insulin resistance (e.g., type 2 diabetes and obesity). Two independent investigators extracted data and assessed study quality. We applied random-effects models to pool Hedge's g standardized mean differences. Insulin resistance was associated with decreased brain glucose metabolism during fasting (-0.47SD, 95%CI: -0.73 to -0.22, p<0.001, I2=71%) and increased metabolism during insulin stimulation (1.44SD, 95%CI: 0.79 to 2.09, p=0.002, I2=43%). Contrary to type 2 diabetes and other insulin resistance-related conditions, obesity was not associated with brain hypometabolism in fasting states (0.29SD, 95%CI: -0.81 to 1.39). Metabolic conditions modify associations between insulin resistance and brain glucose metabolism, i.e. most individuals with insulin resistance display hypometabolism during fasting and hypermetabolism during insulin stimulation.

Identifiants

pubmed: 39185744
pii: 7741559
doi: 10.1210/clinem/dgae570
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.

Auteurs

Nicole J Jensen (NJ)

Department of Endocrinology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Steno Diabetes Neuro Unit, Translational Type 2 Diabetes Research, Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.

Ane J Porse (AJ)

Department of Endocrinology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Steno Diabetes Neuro Unit, Translational Type 2 Diabetes Research, Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.

Helena Z Wodschow (HZ)

Steno Diabetes Neuro Unit, Translational Type 2 Diabetes Research, Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.

Helene Speyer (H)

Copenhagen Research Centre for Mental Health - CORE, Mental Health Centre Copenhagen, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.

Jesper Krogh (J)

Steno Diabetes Neuro Unit, Translational Type 2 Diabetes Research, Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
Clinic for Pituitary Disorders, Department of Medicine, Zealand University Hospital, Denmark.

Lisbeth Marner (L)

Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Bispebjerg, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Michael Gejl (M)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Albert Gjedde (A)

Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Jørgen Rungby (J)

Steno Diabetes Neuro Unit, Translational Type 2 Diabetes Research, Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Classifications MeSH